secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001213900-24-007723
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma authorizes up to $1M share repurchase
-----------------------------------------------------------

- Board authorized up to $1 million of common stock repurchases; no binding commitment.
- Timing, amount and method of repurchases to be determined by market conditions.
- CEO and CFO state authorization reflects confidence in Estrella's value and strategic direction.
- Repurchase program covers stock traded on Nasdaq under ticker ESLA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/0001213900-24-007723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/ea192451-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-007723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer